Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Change in Inventory (2019 - 2025)

Historic Change in Inventory for Sanofi (SNY) over the last 6 years, with Q4 2025 value amounting to -$45.4 million.

  • Sanofi's Change in Inventory rose 9109.28% to -$45.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.5 billion, marking a year-over-year decrease of 372.29%. This contributed to the annual value of -$44.1 million for FY2025, which is 9146.31% up from last year.
  • According to the latest figures from Q4 2025, Sanofi's Change in Inventory is -$45.4 million, which was up 9109.28% from -$509.7 million recorded in Q4 2024.
  • In the past 5 years, Sanofi's Change in Inventory ranged from a high of $16.0 million in Q4 2021 and a low of -$931.8 million during Q4 2023
  • In the last 4 years, Sanofi's Change in Inventory had a median value of -$277.6 million in 2025 and averaged -$367.7 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 11665.54% in 2021, then soared by 4529.52% in 2024.
  • Sanofi's Change in Inventory (Quarter) stood at $16.0 million in 2021, then plummeted by 5917.85% to -$931.8 million in 2023, then skyrocketed by 45.3% to -$509.7 million in 2024, then surged by 91.09% to -$45.4 million in 2025.
  • Its Change in Inventory stands at -$45.4 million for Q4 2025, versus -$509.7 million for Q4 2024 and -$931.8 million for Q4 2023.